Literature DB >> 10505325

Venous thromboembolism, factor V Leiden, and methylenetetrahydrofolate reductase in a sickle cell anemia patient.

A Koren1, L Zalman, C Levin, M Abu Hana, R Mader, S Shalev.   

Abstract

Vaso-occlusive crisis is the most common cause of morbidity in patients with sickle cell anemia (SCA). Central nervous system involvement that leads to hemiplegia is the most frequent neurological complication in those patients. Peripheral deep venous thromboembolism was not reported in SCA patients. Activated protein C resistance is associated with an increased risk of thrombophilia. The authors report an SCA patient with recurrent cerebrovascular accident and deep venous thrombosis. Activated protein C resistance due to factor V Leiden heterozygous and heterozygocity for the methylenetetrahydrofolate reductase were diagnosed and suspected to be the risk factors that contribute to the development of the deep vein thrombosis in this SCA patient.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10505325     DOI: 10.1080/088800199277047

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  3 in total

Review 1.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

2.  Sickle cell disease and venous thromboembolism.

Authors:  Zohreh Rahimi; Abbas Parsian
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-05-24       Impact factor: 2.576

3.  A 19-year-old man with sickle cell disease presenting with spinal infarction: a case report.

Authors:  April Edwards; E Leila Jerome Clay; Valerie Jewells; Stacie Adams; Regina D Crawford; Rupa Redding-Lallinger
Journal:  J Med Case Rep       Date:  2013-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.